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Abstract
Background: The Clinical Global Impression scale (CGI) is frequently used in medical care and
clinical research because of its face validity and practicability. This study proposes to improve the
reliability of the Clinical Global Impression (CGI) scale in depressive disorders by the use of a
semi-standardized interview, a new response format, and a Delphi procedure.
Methods: Thirty patients hospitalised for a major depressive episode were filmed at T1 (first
week in hospital) and at T2 (2 weeks later) during a 5' specific interview. The Hamilton
Depressive Rating Scale and the Symptom Check List were also rated. Eleven psychiatrists rated
these videos using either the usual CGI response format or an improved response format, with
or without a Delphi procedure.
Results:  The new response format slightly improved (but not significantly) the interrater
agreement, the Delphi procedure did not. The best results were obtained when ratings by 4
independent raters were averaged. In this situation, intraclass correlation coefficients were
about 0.9.
Conclusion:  The Clinical Global Impression is a useful approach in psychiatry since it
apprehends patients in their entirety. This study shows that it is possible to quantify such
impressions with a high level of interrater agreement.
Background
The overall impression during an interview is a main ele-
ment of psychiatric evaluation, but it is vague and difficult
to operationalise. The Clinical Global Impression scale
(CGI) is a classic instrument for making global assess-
ments [1]. This scale yields three different measures: 1.
Severity of illness (assessment of patient's current symp-
tom severity, referred to here as CGIs), 2. Global improve-
ment (comparison of patient's baseline condition with
his/her current condition, referred to here as CGIi), 3. Effi-
cacy index (comparison of patient's baseline condition
with a ratio of current therapeutic benefit to severity of
side effects). The CGI has been widely used in clinical
research and especially in clinical trials concerning psy-
chotropic treatments, for bipolar-disorder [2], anxiety [3]
or schizophrenia [4]. Most often, the CGI scale is used
with the same format or wording whatever the pathology
under study. The CGI has nevertheless been more specifi-
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cally adapted for bipolar disorder [2] and schizophrenia
[4]. To our knowledge, there is, to date, no adaptation for
depressive disorders.
The question of the validity of the CGI is still debated
[5,6]. The scale is sensitive enough to differentiate
respondents versus non responders in clinical trials in
depression [7]. Its specificity is however disputed [8]. Cic-
chetti and Prusoff [9] followed 86 patients with a depres-
sive episode for four months; the CGI showed poorer
interrater reliability than the Hamilton Depressive Rating
Scale (HDRS).
Many weaknesses could explain this possible lack of valid-
ity of the CGI: there is no specific interviewer guide avail-
able, and while most other symptoms scales have fairly
clear and specific response options, the response format
used in the CGI to assess change or severity of illness is
more likely to be ambiguous (what is the definition of a
patient who is "Severely ill"?).
This paper proposes a methodology that aims to improve
the validity of CGI severity and improvement scales in the
field of depressive disorders. Content validity will be
improved by the design of a new response format. Inter-
rater reliability will be improved by the drafting of a spe-
cific interviewer guide, a video recording of a specific 5-
minute interview, and a multiple raters procedure using a
short and modified Delphi procedure [10-12] to reach a
consensus in ratings. The Delphi procedure requires the
opinion of subjects each interviewed independently. The
process is iterative: in a first round the subjects are invited
to provide an opinion on a specific matter; in a second
round they are invited again to provide their opinion, but
with the opportunity to change it in view of the group's
response; in a third round they are invited again to pro-
vide their opinion in view of the new group's response,
etc. If an acceptable degree of consensus is obtained the
process may cease.
The hypothesis was that both the new response formats
proposed for the CGIs, and the restricted Delphi proce-
dure, should improve the reliability of ratings in terms of
interrater agreement.
Methods
Design of the "improved" CGI (iCGI)
Response format
The original response format for the CGIs is: 0 "not
assessed", 1 "Normal, not at all ill", 2 "Borderline men-
tally ill", 3 "Mildly ill", 4 "Moderately ill", 5 "Markedly
ill", 6 "Severely ill", 7 "Among the most extremely ill
patients".
To improve the reliability of the severity scale (CGIs) the
proposal is to back up the original response format with
13 case vignettes of patients (a vignette is a short written
portraits, 2 vignettes are proposed for each answer ranging
from 1 to 7 to take into account the heterogeneity of
depressive symptoms). For instance, the response2 "Bor-
derline mentally ill" is supported by the two vignettes:
"The patient complains of periodic tiredness, unhappi-
ness or loss of optimism, but this does not affect his/her
relationships or job", or "Working life and family life are
a little less pleasant for the patient. He/she describes
moments of sadness and internal tension". The objective
is not to directly compare the patient with the description,
but to compare the impression of patient's level of severity
with the impression of level of severity generated by the
patients described in the portraits. In other words, with
the usual CGIs response format the rater's standard for
comparison is implicit and internal, while, with the case
vignette, we propose an explicit and external standard for
comparison.
Some elements of validation are required concerning this
new response format. For this purpose, 6 psychiatrists
were given the 12 case vignettes corresponding to
responses 2 to 7 in a randomised order, and asked to
arrange them in pairs and to order the pairs from the
mildest to the greatest level of severity. Four of the experts
responded in the expected order but two experts reversed
the same two case vignettes (one of the two relating to
response 2 "Borderline mentally ill" and one to response
3 "Mildly ill"). One of these case vignettes was then
slightly modified, after which a new ranking by the two
experts reached the consensus. The final set of case
vignettes is presented in Table 1.
The original response format for the CGIi is: 0 "Not
assessed", 1 "Very much improved", 2 "Much improved",
3 "Minimally improved", 4 "No change", 5 "Minimally
worse", 6 "Much worse", 7 "Very much worse". This for-
mat corresponds to rating improvement on a 0–3 range.
The new proposal is a 0–6 range for improvement, which
is sometimes preferred in terms of sensitivity [13-15], it is
presented in Table 2.
Interview
A clinical interview was specifically developed for the CGI
in the field of depression. The objective of this interview
is to obtain a 5-minute video where the material provided
by the patient is expected to facilitate the formation of an
"impression", an empathetic feeling about the patient's
"essence" [16-19]. This interview is based on the volumi-
nous literature that deals with the application of phenom-
enological concepts in psychiatry, phenomenology being
a philosophical movement where the notions of impres-
sion and essence are central [16,18,19]. A recent review ofBMC Psychiatry 2007, 7:7 http://www.biomedcentral.com/1471-244X/7/7
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the impact of phenomenology in north American psychi-
atric assessment has been proposed by Mona Gupta [20].
The clinical interview is close to day-to-day clinical prac-
tice, it is divided into three stages. The initial stage corre-
sponds to the beginning of the interview. The first
question is "Hello, how are you?". According to the nature
of the response, the following strategies will be adopted.
- The patient expresses his/her inner emotions fluently: no
intervention
- The patient encounters some difficulty talking about
him/herself and remains on a superficial plane: the ques-
tion may be rephrased in a more direct way: "Can you tell
me what is going well and what isn't just now?". The
objective is not necessarily for the patient to answer the
questions, but rather for the person to talk and express
him/herself about how things are at the moment.
The second stage corresponds to the main body of the
interview. The objective is not to direct the patient
towards particular areas but rather to make the interview
as sensitive as possible. A few examples will help:
- The patient digresses: closed questions can be asked:
"Could you be more explicit about this? Could you come
back to that?
- The patient does not digress but gets lost in detail. One
question may be: "What is the main point in what you
said just now?"
- The patient answers, but is not explicit about his/her
inner emotions. Some questions can be suggested to clar-
ify: "What do you mean by this phrase?"
The third stage is the end of the clinical interview. Two
questions can be asked at this point (if they have not been
raised before): "How do you see the future? Do you some-
times think of death?". The final question can be "Can
you say something else about yourself to help us to under-
stand your mind?".
It is noteworthy that silences also play an important role.
Silences arising from the patient (retardation, lack of
Table 2: Improved response format for the Clinical Global 
Impression improvement scale.
6 Ideal improvement




1 Very slight improvement
0 State unchanged.




-5 Very considerable deterioration
-6 Maximum deterioration
Table 1: Improved response format for the Clinical Global Impression severity scale in depression.
Normal, not at all ill
The patient has no symptoms to suggest depression
Borderline mentally ill
The patient complains of periodic tiredness, unhappiness or loss of optimism, but this does not affect his/her relationships or job.
Working life and family life are a little less pleasant for the patient. He/she describes moments of sadness and internal tension.
Mildly ill
The patient is tired, has difficulty taking initiatives or making an effort. Labile mood. At times, deterioration of professional performance.
The patient is tense and irritable. He/she has difficulty concentrating on daily tasks, although he/she mostly gets them done.
Moderately ill
The patient is sad and talks about waves of anxiety. His/her nights are restless. His/her professional life is taking the toll despite efforts to face up to 
it.
The patient has to fight against moments of despair. He/she is exhausted. His/her relationships are affected.
Markedly ill
The patient is listless, says he/she cries easily. He/she is eating irregularly, the face is thin. He/she complains of an impoverished emotional life, he/
she can see no future.
The patient is no longer able to struggle against his/her sad mood. He/she describes a permanent state of internal tension. Everything is difficult to 
bear.
Severely ill
The patient is without reaction, permanently overwhelmed with his/her sad and painful mood. He/she is not eating.
The patient's face and utterance are devoid of affects. He/she has no plans, and says he/she is waiting to die.
Among the most extremely ill patients
The patient is cachectic, utterances are incoherent and centred on morbid themes. Distress is extreme.
The patient is prostrate, eyes averted. The face expresses painful tension. The interview is virtually impossible because of a refusal to communicate. 
The few utterances are delirious.BMC Psychiatry 2007, 7:7 http://www.biomedcentral.com/1471-244X/7/7
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insight) or silences arising from the interviewer (which
may generate restlessness or irritation). From a technical
point of view, the patient's head, chest and hands should
be on the video so that non-verbal behaviours can be cap-
tured.
Procedure
Thirty patients hospitalised for a DSM IV major depressive
episode [21] were included and filmed at T1 (first week in
hospital) and at T2 (2 weeks later). The interview included
the CGI clinical interview presented above and a semi-
structured interview intended to score the HDRS. This last
interview was not filmed and by the way not used for the
CGI ratings. The SCL-90 was then completed by the
patient. All the interviews were conducted by the same
psychiatrist. Videos were sent to raters who were unaware
of each other's identity. Exclusion criteria for patients
were: age < 18 years, language difficulties, neurological
pathologies.
Sampling of raters
Eleven psychiatrists were asked to participate in the study
as raters. They were selected on the basis of a wide variety
of practice and characteristics (psychoanalysts or psycho-
pharmacologists, university hospitals or psychiatric hos-
pitals, young or experienced, etc.), but, deliberately, none
had more than limited experience in the use of psychiatric
scales. These selection criteria were decided on so that
interrater agreement could not be suspected of being over-
estimated due to excessive homogeneity among the raters.
The eleven raters were randomised into three groups.
Three raters (group 1) were asked to rate the videos with
the original response formats for the CGIs and CGIi. Four
others (group 2) were asked to rate the videos with the
new response formats for the CGIs and CGIi. The last four
raters (group 3), were divided into two pairs (pair 1 and
pair 2), each of these pairs worked with the new response
formats of the CGIs and CGIi and with a restricted Delphi
procedure. The scoring process for this was as follows: in
a first round, each expert rates the CGIs and the CGIi. In a
second round, each expert receives the assessment by the
other expert, reviews the videos and again rates the CGIs
and the CGIi. In a third round, the ratings obtained are
averaged between experts.
These three groups were then used to assess and compare
the reliability (in terms of interrater agreement) of the tra-
ditional response formats of CGIs and CGIi, the new
response formats and the restricted Delphi procedure. It is
also of a potential interest to assess the reliability of the
average of the ratings by 4 independent clinicians. 4 rat-
ings are proposed here since the restricted Delphi proce-
dure also requires 4 evaluations (2 raters on 2 occasions):
thus the workload of the two approaches is comparable.
In practice, group 2 was therefore used to assess the relia-
bility of the average of 4 ratings (see statistical section for
details).
Sampling of patients
Patients were hospitalised in Kremlin-Bicêtre university
hospital psychiatric department, Paul Brousse university
hospital psychiatric department and Clermont de l'Oise
psychiatric hospital.
Statistical methods
Interrater agreement is assessed using the intraclass corre-
lation coefficient (ICC) as defined by the ratio of the inter-
patient variance to the sum of the inter-patient variance,
the interrater variance and the residual variance [22]. In
group 1 three ratings are used for each patient. In group 2
four ratings are used. In group 3, two ratings are used,
each derived from the mean of the last 2 ratings observed
in each pair. It is noticeable that even if the intraclass cor-
relation coefficients are obtained from different numbers
of raters (i.e. three for group 1, four for group 2 and three
for group 3), it is nevertheless possible to compare them
statistically without any bias. However, in an ideal exper-
imental design, 4 raters could have been preferred in
group 1 so that a comparable precision of the estimated
ICC would have been obtained in group 1 and in group 2.
Interrater agreement for the mean of 4 ratings derived
from 4 independent psychiatrists can be estimated from
group 2. In this situation, the intraclass correlation coeffi-
cient is obtained from the ratio of the inter-patient vari-
ance to the sum of the inter-patient variance, the interrater
variance divided by 4 and the residual variance divided by
4 [23]. This formula shows that it is possible to estimate
the intraclass correlation coefficient of a mean of k ratings
even if fewer raters are available during the validation pro-
cedure.
A preliminary estimate of responsiveness is assessed by
the effect size as defined by the ratio of the difference in
raw scores between the two times of evaluation to the
standard deviation of the score in the first time group
[24].
Confidence intervals of intraclass coefficients (ICC) and
effect sizes (ES) are obtained by a bootstrap procedure.
Statistical tests of significance of ICC and ES are obtained
using a bootstrap procedure which takes into account that
the same population is used to compare these coefficients.
All statistical analyses were carried out on R 1.9 software
and its "boot" and "psy" library [25].
Ethics
Each patient signed an authorisation for the video and for
the participation in the research. The protocol wasBMC Psychiatry 2007, 7:7 http://www.biomedcentral.com/1471-244X/7/7
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approved by the "Comité d'évaluation éthique de
l'inserm" (IRB0000388, FWA00005831).
Results
Among the 30 patients included there were 25 females;
the mean age was 49 years, with a standard-deviation of
12 years and a range of 27 to 80 years.
At T1, the HDRS, SCL90 and CGIs scores for group 1,
group 2 and group 3 were highly correlated with a mean
Pearson correlation coefficient of 0.74. More precisely, the
Pearson correlation coefficient of the mean of CGIs scores
for group 1, 2 and 3 and HDRS was equal to 0.81. The cor-
relation of this mean of CGIs scores and SCL90 was equal
to 0.62. The correlation between the HDRS and the SCL90
was equal to 0.69.
Table 3 presents the intraclass correlation coefficients
which estimate the interrater reliability in groups 1, 2, 3
and 2' (the average of 4 ratings). All values are above 0.6,
which corresponds to "good" to "excellent" agreement.
All values for 2' (the average of 4 ratings) are above 0.75
which is considered to be "excellent" [26-28]. The hypoth-
eses were that agreement in group 2 (new response for-
mat) would be more marked than agreement in group 1
(usual response format), and that agreement in group 3
(new response format and Delphi procedure) would be
greater than agreement in group 2 (new response format
only): data did not really support these hypotheses. If the
level of agreement in group 2 appears systematically
slightly superior to the level of agreement in group 1, this
difference is however statistically significant only for the
CGIs at T2. The Delphi procedure appears inefficient since
the levels of agreement in group 3 are comparable with
the levels of agreement in group 2. The level of agreement
in group 2' (the average of 4 CGI scores obtained with the
new response format) is higher than in group 2. These dif-
ferences are inevitable from a statistical point of view and
by the way cannot be tested, they are ranging from 0.23 to
0.14. It is also noticeable that the level of agreement in
group 2' is systematically higher than in group 3 while the
same amount of clinical workload is engaged. These dif-
ferences in levels of agreement between group 2' and
group 3 are significant at the 5% level for CGIs at T2, for
the difference of CGIs between T2 and T1 and for CGIi.
These results suggest to compare the level of agreement
between the average of 4 CGI scores obtained with the
new response format (group 2') and the average of 4 CGI
scores obtained with the usual response format (which
could correspond to a group 1'). For group 1', we have
then: at T1, ICC = 0.88 (0.88 also for group 2'); at T2, ICC
= 0.90 (0.94 for group 2'); for the difference between T2
and T1, ICC = 0.88 (0.91 for group 2') and for the CGIi,
ICC = 0.88 (0.92 for group 2'). Here again, these differ-
ences are statistically significant only at T2.
The lack of efficiency of the Delphi procedure may be
explained in part from the fact that the two raters in pair
1 are rather divergent in their first rating and they main-
tain their position in their second rating (data not
shown).
Table 4 presents effect sizes computed from variations in
scores between T1 and T2 using the Cohen d formula [24].
Table 4 shows that the effect size is larger in group 2' (ES
= 1.02) than with the HDRS scale (ES = 0.61) or with the
SCL90 scale (ES = 0.54). This difference in effect size is sig-
nificant at the 5% level.
Discussion
This paper suggests that, in the field of depression, a Clin-
ical Global Impression, when elaborated with an appro-
priate methodology, can be operationalised into a reliable
measure. This "improved" CGI (iCGI) entails a specific 5'
video-recorded clinical interview, a new response format
and a group of 4 independent clinicians to score the vid-
eos. The average of the 4 scores is considered as the final
measurement.
Data tends to show that, in depression, the group of inde-
pendent clinicians do not need to conduct a Delphi pro-
cedure: if clinicians are too far from each other in the first
round, it appears that they do not move towards consen-
Table 3: Intraclass correlation coefficient of CGI ratings and their 95% confidence intervals. CGIs measures severity at T1 (CGIs1) at 
T2 (CGIs2) and CGIi improvement between T2 and T1. CGIs1–2 measures the difference between the CGI severity scores measured 
at T2 and T1. Group 1 corresponds to 3 raters using the traditional CGI response format. Group 2 corresponds to 4 raters using the 
improved response format. Group 3 corresponds to a pair of ratings derived from a restricted Delphi procedure (each rating is 
obtained from 2 clinicians) and using the improved response format. Group 2' is Group 2, but the intraclass correlation coefficient 
computed here estimates the reliability of the average of 4 ratings derived from independent raters.
CGIs1 95% C.I. CGIs2 95% C.I. CGIs1–2 95% C.I. CGIi 95% C.I.
Group 1 0.64 [0.38, 0.77] 0.70 [0.53, 0.81] 0.64 [0.49, 0.77] 0.65 [0.39, 0.79]
Group 2 0.65 [0.40, 0.79] 0.80 [0.70, 0.87] 0.74 [0.54, 0.82] 0.74 [0.56, 0.84]
Group 3 0.86 [0.72, 0.93] 0.74 [0.57, 0.85] 0.69 [0.41, 0.84] 0.71 [0.53, 0.81]
Group 2' 0.88 [0.73, 0.94] 0.94 [0.90, 0.96] 0.91 [0.79, 0.95] 0.92 [0.83, 0.95]BMC Psychiatry 2007, 7:7 http://www.biomedcentral.com/1471-244X/7/7
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sus in the next round. If the Delphi method can establish
consensus for diagnosis in the carpal tunnel syndrome
[11], it does not seem to work for the assessment of inten-
sity of depression. Therefore, a group of 4 clinicians whose
evaluations are averaged will be preferred to a group of 2
clinicians using a two-round Delphi procedure.
A response format specific to the field of depression has
been developed. Its use results in a slight increase in inter-
rater reliability which is nevertheless statistically signifi-
cant only at T2. It can be suggested then to use the case
vignettes for the iCGI severity scale and the -6/0/6
response format instead of the usual -3/0/3 one for the
iCGI improvement scale. This last point was not evident
since there is an old controversy about the optimal
number of response categories in rating scales [13-15]. It
is remarkable that this limited benefit induced by the new
response format makes it conceivable to use the iCGI with
the usual response format of the CGIs and CGIi. The iCGI
could be used by the way in other fields than depression.
It could be objected that there was no use of a structured
interview to assess the diagnosis of DSM IV major depres-
sive episode. But the iCGI is designed to deal with a broad
spectrum of depressive disorders.
It could also be objected that the iCGI is much more
demanding than a classic HDRS. Our experience does not
confirm this. The 5-minute video-recording is not a real
burden for the clinician: the use of a high-resolution web-
cam and a microphone plugged into a computer make
things quite simple. For a given evaluation, an iCGI
requires about 30 minutes: 5 minutes for the interview, 5
minutes × 4 for the ratings plus 5 minutes "down-time".
Moreover, the use of video makes it possible to imple-
ment quality control procedures, and the short duration
of the interview makes it possible to replicate assessment
in a given day at different times, in order to reduce the
error component due to nycthemeral fluctuations. How-
ever, there is no doubt that such a procedure will be very
difficult to implement in a population based study.
An encouraging but preliminary result resides in the effect
sizes. The iCGI sensitivity to change which is demon-
strated by the effect sizes is significantly and substantially
larger than the HDRS. This can be translated in terms of
numbers of subjects to include in a study, for a given
power and to show a given difference. A protocol that
would require 300 subjects with the HDRS, would require
only 119 patients with the iCGI. Of course, these results
should be confirmed, for example because the effect sizes
are computed on T1/T2 measurements and not on treat-
ment groups. Furthermore, this result makes sense only if
measurement error is the main source of error. In the field
of depression, circadian fluctuations of symptoms are
important and may be an important source of variance. A
repetition of iCGI evaluations within or across days could
then be necessary in order to improve substantially the
power of studies.
Of course, one of the most important drawback often
opposed to the CGI, its lack of specificity [8], may also be
opposed to the iCGI. Indeed, when used in depressed
patients, the CGI scales capture potentially, in unknown
proportions, many characteristics that are not strictly
related to the depressive symptomatology. Personality
traits, comorbidity, level of dangerousness, level of func-
tioning are among these characteristics. Two arguments
may be proposed to soften this drawback. First, the new
response format of the iCGIs is likely to help the clinician
to focus on the depressive dimension. Second, when
assessing the efficiency and even the efficacy of a drug or
more generally of a treatment, it is actually useful to have
an outcome measurement that does not concentrate only
on the academic disorder under study, but rather on the
patient himself, grasped in his/her entirety.
Conclusion
The iCGI could be an interesting tool in the global evalu-
ation of psychiatric patients. It is studied here in the field
of depression. Its clinical relevance, interrater reliability,
sensitivity to change and possibility to implement quality
control processes make it of a potential use in many areas
of clinical research in psychiatry.
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